Notice2025-18906

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 30, 2025

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 187 (Tuesday, September 30, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 187 (Tuesday, September 30, 2025)]
[Notices]
[Pages 46893-46894]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-18906]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-25-1011]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Emergency Epidemic Investigation (EEI)'' to 
the Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on June 16, 2025 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a> Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Emergency Epidemic Investigations (EEI) (OMB Control No. 0920-1011, 
Exp. 12/31/2025)--Extension--Office of Science (OS), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    CDC previously conducted Emergency Epidemic Investigations (EEIs) 
under Office of Management and Budget (OMB) Control Number 0920-0008. 
In 2013, CDC received OMB approval (OMB Control No. 0920-1011) for a 
New Generic Clearance to collect vital information during EEIs in 
response to outbreaks or other urgent public health events (i.e., 
natural, biological, chemical, nuclear, radiological) characterized by 
undetermined agents, undetermined sources, undetermined transmission, 
or undetermined risk factors. This Generic Clearance has been approved 
for a number of Extensions since 2013 and expires on 12/31/2025. CDC 
seeks OMB approval for an additional Extension of this Generic 
Clearance for another three-year period.
    Supporting effective EEIs is one of the most important ways that 
CDC protects the health of the public. CDC is frequently called upon to 
conduct EEIs at the request of local, state, or international health 
authorities seeking support to respond to outbreaks or urgent public 
health events. In response to external partner requests, CDC provides 
the necessary epidemiologic support to identify the agents, sources, 
modes of transmission, or risk factors to effectively implement rapid 
prevention and control measures to protect the public's health. Data 
collection is a critical component of the epidemiologic support 
provided by CDC; data are analyzed to determine the agents, sources, 
modes of transmission, or risk factors so that effective prevention and 
control measures can be implemented. During an unanticipated outbreak 
or urgent public health event, immediate action by CDC is necessary to 
minimize or prevent public harm. The legal justification for EEIs is 
found in the Public Health Service Act (42 U.S.C. 301 [241] (a).
    Successful investigations are dependent on rapid and flexible data 
collection that evolves during the investigation and is customized to 
the unique circumstances of each outbreak or urgent public health 
event. Data collection elements will be those necessary to identify the 
agents, sources, mode of transmission, or risk factors. Examples of 
potential data collection methods include telephone or face-to-face 
interviews; email, web, or other types of electronic questionnaires; 
paper-and-pencil questionnaires; focus groups; medical record review 
and abstraction; laboratory record review

[[Page 46894]]

and abstraction; collection of clinical samples; and environmental 
assessments. Respondents will vary depending on the nature of the 
outbreak or urgent public health event; examples of potential 
respondents include health care professionals, patients, laboratorians, 
and the general public. Participation in EEIs is voluntary and there 
are no anticipated costs to respondents other than their time. CDC will 
use the information gathered during EEIs to rapidly identify and 
effectively implement measures to minimize or prevent public harm.
    CDC projects 20 EEIs in response to outbreaks or urgent public 
health events characterized by undetermined agents, undetermined 
sources, undetermined transmission, or undetermined risk factors 
annually. The projected average number of respondents is 200 per EEI, 
for a total of 4,000 respondents. CDC estimates the average burden per 
response is 0.5 hours and each respondent will be asked to respond 
once. Therefore, CDC requests OMB approval for an estimated 2,000 
annual burden hours. These estimates are based on the reported burden 
for EEIs that has been performed during the previous approval periods.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Emergency Epidemic Investigation        Emergency Epidemic                 4,000               1           30/60
 Participants.                           Investigation Data
                                         Collection Instruments.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2025-18906 Filed 9-29-25; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on September 30, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.